| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |